氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描用于监测乳腺癌患者新辅助化疗的反应。 - Suppr

Suppr

超能文献

FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients.

作者信息

Dalus Katharina, Rendl Gundula, Rettenbacher Lukas, Pirich Christian

出版信息

Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1992-3. doi: 10.1007/s00259-010-1585-z. Epub 2010 Aug 11.

DOI:10.1007/s00259-010-1585-z

PMID:20700738

Abstract

摘要

相似文献

FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients.

Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1992-3. doi: 10.1007/s00259-010-1585-z. Epub 2010 Aug 11.

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):419-25. doi: 10.1007/s00259-010-1660-5.

Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.

Clin Breast Cancer. 2013 Aug;13(4):271-9. doi: 10.1016/j.clbc.2013.02.003. Epub 2013 May 25.

18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.

Oncotarget. 2015 Oct 6;6(30):29388-95. doi: 10.18632/oncotarget.5001.

Positron emission tomography/computed tomography in locally advanced breast cancer.

Exp Oncol. 2013 Dec;35(4):253-7.

18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.

Acta Radiol. 2012 Jul;53(6):615-27. doi: 10.1258/ar.2012.110603. Epub 2012 Jun 25.

Subtype-Guided F-FDG PET/CT in Tailoring Axillary Surgery Among Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: A Feasibility Study.

Oncologist. 2020 Apr;25(4):e626-e633. doi: 10.1634/theoncologist.2019-0583. Epub 2019 Dec 11.

PET/CT with [18F] fluorodeoxyglucose in the assessment of metabolic response to neoadjuvant chemotherapy in locally advanced breast cancer.

Q J Nucl Med Mol Imaging. 2012 Jun;56(3):291-8.

Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?

Eur J Surg Oncol. 2013 Dec;39(12):1358-63. doi: 10.1016/j.ejso.2013.08.025. Epub 2013 Oct 2.

18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

J Nucl Med. 2013 Nov;54(11):1862-8. doi: 10.2967/jnumed.112.119271. Epub 2013 Oct 3.

引用本文的文献

Additional value of F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.

Cancer Imaging. 2017 May 25;17(1):15. doi: 10.1186/s40644-017-0117-5.

Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1309-18. doi: 10.1007/s00259-013-2657-7. Epub 2014 Apr 18.

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):852-63. doi: 10.1007/s00259-012-2077-0. Epub 2012 Mar 6.

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.

Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1029-36. doi: 10.1007/s00259-011-1735-y. Epub 2011 Feb 10.

本文引用的文献

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Ann Surg Oncol. 2009 Dec;16(12):3366-74. doi: 10.1245/s10434-009-0660-9. Epub 2009 Sep 4.

18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1551-7. doi: 10.1007/s00259-009-1116-y. Epub 2009 Mar 27.

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

J Clin Oncol. 2009 Feb 1;27(4):535-41. doi: 10.1200/JCO.2008.17.2650. Epub 2008 Dec 15.

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.

Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):1915-24. doi: 10.1007/s00259-007-0459-5. Epub 2007 Jun 20.

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

J Clin Oncol. 2006 Dec 1;24(34):5366-72. doi: 10.1200/JCO.2006.05.7406. Epub 2006 Nov 6.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

J Natl Cancer Inst. 2000 Feb 2;92(3):205-16. doi: 10.1093/jnci/92.3.205.

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.

Cancer J Sci Am. 1998 Mar-Apr;4(2):125-31.

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.

Br J Cancer. 1998 Feb;77(4):621-6. doi: 10.1038/bjc.1998.99.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验